William Barchuk, Senior Director of Translational Medicine Development at Janssen R&D will be presenting 'A Phase 2a, Randomized, Controlled Study of JNJ-40929837, an LTA4H inhibitor, in Patients with Asthma' at GTC's 2nd Allergy & Respiratory Drug Discovery Conference Taking Place in San Diego, CA on January 31st - February 1st, 2013.
Jacques Descotes Professor and Head at the Poison Center and Pharmacovigilance Department at Lyon University General Hospitals, Lyon, France Will Give A Feature Presentation at the Inaugural Immunogenicity and Immunotoxicity Conference (Jan 31 - Feb 1, 2013 in San Diego, CA).
Ron Levy, Professor of Medicine & Chief, Division of Oncology at Stanford University will give a Featured Presentation on "Antibody Therapy of Cancer: Targeting the Cancer Cell and Targeting the Immune System" at the 5th ImmunoTherapeutics & ImmunoMonitoring Conference (Jan 31 - Feb 1, 2013 in San Diego, CA).
Rab Prinjha, Interim Head of Epinova Epigenetics DPU and Head of Biology at GlaxoSmithKline will give a featured presentation on "Epigenetic Modification in the Treatment of Immunoinflammatory Diseases" at the 2nd Epigenetics in Drug Discovery Conference taking place on Nov 8-9, 2012 in Boston, MA.
Peter Sandy, Senior Scientist at Constellation will give a presentation on "4SC Preclinical Evaluation of BET Bromodomain Inhibitors for the Treatment of Cancer" at the 2nd Cancer Epigenetics conference taking place on Nov 8-9, 2012 in Boston, MA.
Clemens Krepler, Staff Scientist of Meenhard Herlyn Laboratory, Tumor Microenvironment and Metastasis Program at Melanoma Research Center of The Wistar Institute Will Give a Presentation at the Protein Kinases and Drug Design Conference (Nov 8-9, 2012 in Boston, MA).
John Richard Morphy, Senior Research Advisor of Medicinal Chemistry at Eli Lilly will give a presentation on "Designing Selectively Non-selective Drugs" at the Protein Kinases and Drug Design conference taking place on Nov 8-9, 2012 in Boston, MA.
Puja Sapra, Director, Oncology Research Unit at Pfizer Will Give a Featured Presentation at the 5th ImmunoTherapeutics & ImmunoMonitoring Conference (Jan 31 - Feb 1, 2013 in San Diego).
Tecan and JPT Peptide Technologies GmbH, a wholly-owned subsidiary of BIONTECH AG, today announced a collaborative agreement between the two specialist companies.
Glenn D. Prestwich, Presidential Professor, Director of Therapeutic Biomaterials Center, and Special Presidential Assistant for Faculty Entrepreneurism of Medicinal Chemistry at the University of Utah Will Give a Plenary Keynote Presentation at the 8th Modern Drug Discovery & Development Summit (October 24-26, 2012 in Philadelphia, PA)
Biotage® (STO: BIOT), introduced EVOLUTE® EXPRESS, a novel family of 96-well plates that simplify polymer-based SPE by employing a streamlined 3-step protocol; Load-Wash-Elute.
Biotage® (STO: BIOT), introduced an innovative new synthesis platform for peptide researchers at the 2012 European Peptide Symposium in Athens, Greece.
Biotage® (STO: BIOT), announces that Biotage is in late stage development with its partner Microsaic Systems plc of a fully integrated solution for Mass Directed Flash with Biotage's flagship flash purification system Isolera™.
Lyn H. Jones, Senior Director and Head of Chemical Biology & Rare Diseases Chemistry at Pfizer will give a featured presentation on "Applying Kinase Chemical Biology to Advance Drug Discovery" at the Protein Kinases and Drug Design conference taking place on Nov 8-9, 2012 in Boston, MA.
Marcie Glicksman, Senior Director of the Leads Discovery Group of LDDN at Harvard University will give a presentation on "Strategies for Discovery of Kinase Inhibitors for Neurodegenerative Diseases" at the Protein Kinases and Drug Design conference taking place on Nov 8-9, 2012 in Boston, MA.
Barry Morgan, Vice President of Molecular Discovery Research at GlaxoSmithKline will give a plenary keynote presentation on "DNA Encoded Libraries - A Disruptive Innovation for Molecular Discovery?" at the 8th Modern Drug Discovery & Development Summit taking place on October 24-26, 2012 in Philadelphia, PA
Hella Kohlhof, Manager of Translational Pharmacology at 4SC AG will give a presentation on "4SC-202: A Novel Epigenetic Modulator to Target Cancer Stem Cells"
Paul Kusserow and Marvin O'Quinn will serve as keynote speakers at the Neuroscience & Stroke Centers Executive Leadership Conference, GTC is pleased to announce.
Jianguo Li, Director & Senior Principal Scientist, Clinical Pharmacology at Astrazeneca Will Give a Featured Presentation on "Prediction of the Outcome of a Thorough QT study by PK/PD modeling - Issues for consideration" at the 3rd Pharmacokinetics & Pharmacodynamics Conference (Oct 24-26, 2012 in Philadelphia, PA)
The National Institutes of Health will address the Small Business Innovation Research (SBIR)'s Role in Working to Advance the Biotechnology Industry at the Biotechnology Transfer & Commercialization Conference.
Eduardo Marban, Director & Mark S. Siegel Family Professor of Cedars-Sinai Heart Institute to give a Keynote Presentation at the 9th Stem Cell Research & Therapeutics Conference (Oct 24-26, 2012 in Philadelphia, PA).
Jane Lebkowski, President & Chief Scientific Officer, Regenerative Patch Technologies (Former VP & CSO, Geron) to Discuss "iPS & hESC Sourced Pluripotent Cells: Best Uses for Each Technology" at the 9th Stem Cell Research & Therapeutics Conference (Oct 24-26, 2012 in Philadelphia, PA).
Griaule Biometrics has released their new version of their biometric cloud service the Griaule Biometric Framework 2.0. Version 2.0 now supports the ability to enroll fingerprints, face, and voice. The goal of this software is to help developers easily integrate biometric support into any application.
Griaule Biometrics has partnered with Diebold, and Lumidigm to provide biometric fingerprint recognition for Caixa Economica Federal ATMs in Brazil. The goal is to provide Caixa 58 million customers with a safe and easy process to access their bank accounts at electronic terminals that does not rely on a password.
By long-term providing DNA plasmid under GLP condition for our in-house downstream services, such as transient protein expression, stable cell line construction, and antibody drug development, GenScript has established superior laboratory for GLP service that other suppliers cannot achieve.
Shafique Virani, Global Head of CNS Business Development & Licensing at F. Hoffmann-La Roche will give a featured presentation on the "Role of Business Development in Building and Enabling a World Class CNS Portfolio" at the 5th CNS Partnering and Deal-making Conference to be held in San Francisco, CA on September 13-14, 2012.
Lubor Gaal, Head of Strategic Transactions Group, Europe, at Bristol-Myers Squibb, will give a featured presentation at the 5th CNS Partnering and Deal-making Conference (Sept 13-14, 2012 in San Francisco, CA).
Satisfied Users & 
Approved Press Releases
